212 related articles for article (PubMed ID: 17724117)
1. A Skp2 autoinduction loop and restriction point control.
Yung Y; Walker JL; Roberts JM; Assoian RK
J Cell Biol; 2007 Aug; 178(5):741-7. PubMed ID: 17724117
[TBL] [Abstract][Full Text] [Related]
2. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
Liu S; Yamauchi H
Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
[TBL] [Abstract][Full Text] [Related]
3. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2.
Rodier G; Makris C; Coulombe P; Scime A; Nakayama K; Nakayama KI; Meloche S
J Cell Biol; 2005 Jan; 168(1):55-66. PubMed ID: 15631990
[TBL] [Abstract][Full Text] [Related]
4. Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset.
Yuan X; Srividhya J; De Luca T; Lee JH; Pomerening JR
Mol Biol Cell; 2014 Feb; 25(4):441-56. PubMed ID: 24356446
[TBL] [Abstract][Full Text] [Related]
5. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
6. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation.
Sarmento LM; Huang H; Limon A; Gordon W; Fernandes J; Tavares MJ; Miele L; Cardoso AA; Classon M; Carlesso N
J Exp Med; 2005 Jul; 202(1):157-68. PubMed ID: 15998794
[TBL] [Abstract][Full Text] [Related]
7. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.
Ji P; Jiang H; Rekhtman K; Bloom J; Ichetovkin M; Pagano M; Zhu L
Mol Cell; 2004 Oct; 16(1):47-58. PubMed ID: 15469821
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells.
Egozi D; Shapira M; Paor G; Ben-Izhak O; Skorecki K; Hershko DD
FASEB J; 2007 Sep; 21(11):2807-17. PubMed ID: 17475922
[TBL] [Abstract][Full Text] [Related]
10. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
12. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
Salamina M; Montefiore BC; Liu M; Wood DJ; Heath R; Ault JR; Wang LZ; Korolchuk S; Baslé A; Pastok MW; Reeks J; Tatum NJ; Sobott F; Arold ST; Pagano M; Noble MEM; Endicott JA
J Mol Biol; 2021 Mar; 433(5):166795. PubMed ID: 33422522
[TBL] [Abstract][Full Text] [Related]
13. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
[TBL] [Abstract][Full Text] [Related]
14. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
Wang Z; Hu H; Li G; Lee HJ; Jiang C; Kim SH; Lü J
Int J Cancer; 2008 Jan; 122(1):15-24. PubMed ID: 17847021
[TBL] [Abstract][Full Text] [Related]
15. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
16. p38 MAPK regulates G1-S transition in hypoxic cardiac fibroblasts.
Pillai MS; Sapna S; Shivakumar K
Int J Biochem Cell Biol; 2011 Jun; 43(6):919-27. PubMed ID: 21420505
[TBL] [Abstract][Full Text] [Related]
17. Antimitogenesis linked to regulation of Skp2 gene expression.
Stewart SA; Kothapalli D; Yung Y; Assoian RK
J Biol Chem; 2004 Jul; 279(28):29109-13. PubMed ID: 15126498
[TBL] [Abstract][Full Text] [Related]
18. A reciprocal relationship between Rb and Skp2: implications for restriction point control, signal transduction to the cell cycle and cancer.
Assoian RK; Yung Y
Cell Cycle; 2008 Jan; 7(1):24-7. PubMed ID: 18196971
[TBL] [Abstract][Full Text] [Related]
19. Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase.
Xu S; Abbasian M; Patel P; Jensen-Pergakes K; Lombardo CR; Cathers BE; Xie W; Mercurio F; Pagano M; Giegel D; Cox S
J Biol Chem; 2007 May; 282(21):15462-70. PubMed ID: 17409098
[TBL] [Abstract][Full Text] [Related]
20. A novel target of mizoribine inhibiting mesangial cell proliferation: S phase kinase-associated protein 2.
Liu S; Xie Y; Lv Y; Qin F; Fu B; Shi S; Yin Z; Hong Q; Zhang X; Wang J; Chang M; Chen X
Am J Nephrol; 2010; 32(5):447-55. PubMed ID: 20924167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
